Skip to main content

T50.993D ICD-10-CM Code: Poisoning by other drugs, medicaments and biological substances, assault, subsequent encounter

Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.

Coding at a Glance

Inpatient Payment Groups (MS-DRG)

Potential MS-DRG participation — not a DRG assignment.

MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v43, Appendix B.

A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.

Coding instructions

Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for T50.993D in the official ICD-10-CM tabular list, quoted as published.

Notes without a marker are published on T50.993D itself; “inherited from” names the category or block whose note applies here.

Includes

Conditions the official ICD-10-CM tabular list includes under this code.

  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed

Source: inherited from T36-T50

Excludes1 — Not Coded Here

Conditions generally not reported together with this code (Excludes1) -- an error unless the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).

Source: inherited from T36-T50

Excludes2 — Not Included Here

Conditions not covered by this code, but which may be reported alongside it when both are present.

Source: inherited from T36-T50

Code First

Underlying conditions that must be sequenced before this code.

  • Code first, for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)
    N14.0-N14.2: N14.0, N14.1, N14.11, N14.19, N14.2

Source: inherited from T36-T50

Use Additional Code

Supplementary codes the tabular list directs you to add.

  • Use additional code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
    Y63.8-Y63.9: Y63.8, Y63.9
  • underdosing of medication regimen (Z91.12-, Z91.13-)

Source: inherited from T36-T50

7th Character Guide

"The appropriate 7th character is to be added to each code from category T50"

  • A — initial encounter
  • D — subsequent encounter (this page’s code)
  • S — sequela

How the encounter character is assigned. “Initial encounter” means the patient is receiving active treatment for the condition — it is not limited to the first visit, and a different or new provider giving active treatment still assigns it. “Subsequent encounter” covers care during the healing or recovery phase after active treatment. “Sequela” is for complications or conditions that arise as a direct result of the original condition.

ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.19.a (paraphrased by MedCoder).

Variant codes in this family

T50.993A, T50.993D, T50.993S

Character meanings are CMS's official 7th-character extensions for this family, as carried in each variant code's official description; variant codes are registry rows. The explanation of how the encounter character is assigned is MedCoder editorial, distinct from the official content above it.

Coder workflow for T50.993D

MedCoder structured workflow — derived from this code’s own official record

Before you code T50.993D

  1. A 7th character is required in this family. Confirm the documented encounter: initial (active treatment), subsequent (healing or recovery phase), or sequela. This page’s code carries “D”. “Initial” means active treatment, not the first visit (Guidelines I.C.19.a).

    See the 7th Character Guide · Guide: 7th characters: initial, subsequent, sequela →

  2. Confirm whether the documentation describes a poisoning, an adverse effect of a correctly prescribed and administered drug, an underdosing, or a toxic effect, and the intent where the record states it: the Table of Drugs and Chemicals separates these by column, and the sequencing differs for each. Poisoning, adverse effect and underdosing guidelines (Guidelines I.C.19.e).

    See the Table of Drugs and Chemicals entries · Guide: Poisoning vs adverse effect vs underdosing →

  3. Check the Excludes1 note: if the documentation supports a condition named there, do not simply proceed with T50.993D. Excludes1 conditions are not reported together with this code unless the record shows they are unrelated (Guidelines I.A.12.a).

    See the official tabular notes

Choose the right path

  1. Does the documentation support a condition named in T50.993D’s Excludes1 note?
    Yes → Do not simply proceed: review the excluded code. Both are reported only when the record shows the two conditions are unrelated.
    No → Continue.

    ReviewO29.3

  2. Is the underlying (etiologic) condition the Code First note names documented?
    Yes → Sequence the underlying condition first, then T50.993D.
    No → Continue; do not add an underlying condition the record does not document.

    ReviewT88.7, K29, L27

  3. Is the encounter phase documented — active treatment, healing or recovery, or a sequela?
    Yes → Assign the matching 7th character; the variant codes are in the 7th Character Guide.
    No → The code is invalid without its 7th character — query for the missing element.

Consider T50.993D. Then work the Use Additional Code note, and confirm the code is valid for the date of service in the Verify section.

Documentation check

The provider’s diagnostic statement
Codes are assigned from the provider’s documented diagnosis, not from clinical criteria, test values or a medication list (Guidelines I.A.19).
Encounter type
Active treatment, healing or recovery phase, or sequela — the basis of the 7th character (Guidelines I.C.19.a).
The underlying (etiologic) condition
Named in the Code First note; sequenced before this code when documented (Guidelines I.A.13).
The conditions the Use Additional Code note names
Reported with this code when documented; a conditional instruction (“if applicable”, “if known”) applies only when the record supports it.
External cause, place and activity
For the external cause codes reported with the injury or poisoning, where documented (Guidelines I.C.20.a).

Official instructions as workflow

  • Excludes1 — check before selecting T50.993D(1 note)

    Coding workflow: If the documentation supports a condition named in this note, do not simply proceed with T50.993D: the two are not reported together. The one exception is when the record shows the two conditions are unrelated to each other.

    CompareO29.3

    See the official tabular notes · Guidelines I.A.12.a

  • Excludes2 — not part of T50.993D(5 notes)

    Coding workflow: The conditions named in this note are not included in T50.993D. When the record documents both, both may be reported; the note is a boundary, not a prohibition.

    CompareF55, D84.821

    See the official tabular notes · Guidelines I.A.12.b

  • Code First — sequencing check(7 notes)

    Coding workflow: Check whether the underlying or etiologic condition the note names is documented. When it is, sequence it before T50.993D. Do not add an underlying condition the record does not document.

    ReviewT88.7, K29, L27

    See the official tabular notes · Guidelines I.A.13

  • Use Additional Code — after identifying T50.993D(4 notes)

    Coding workflow: Check whether the documentation supports the additional code(s) the note names, and report them with T50.993D when it does. Where the instruction is conditional (“if applicable”, “if known”), it applies only when the record documents the condition.

    ReviewY63.6, Z91.12, Z91.13

    See the official tabular notes · Guidelines I.A.13

Coding decision scenarios

Pattern scenarios for this code’s structure — decision rules, not clinical cases

Documentation: Both the condition T50.993D describes and a condition named in its Excludes1 note are documented for the same encounter.

Coding question: Can both codes be reported?

Path: Review the Excludes1 note and the excluded code, and look for a provider statement on whether the two conditions are related.

Reason: Excludes1 means the two are not coded together; the exception is when the record shows the conditions are unrelated to each other (Guidelines I.A.12.a).

ReviewO29.3

Documentation: The patient returns during the healing or recovery phase after active treatment of the same condition.

Coding question: Which 7th character applies?

Path: Review the official 7th-character definitions for this family in the 7th Character Guide.

Reason: “Initial encounter” means active treatment, not the first visit; care during recovery takes “subsequent encounter”, and a complication arising from the original condition takes “sequela” (Guidelines I.C.19.a).

Documentation: The underlying condition the Code First note names is documented alongside this condition.

Coding question: How are the two sequenced?

Path: Review the Code First note.

Reason: The underlying condition is sequenced first and the manifestation follows (Guidelines I.A.13).

ReviewT88.7, K29, L27

Every row is derived from this code’s own record — its title, tabular notes, 7th-character family and same-category siblings — with fixed MedCoder wording; nothing is inferred about a patient. The official notes and guideline text are in the sections each row links to, and they control.

Code Overview

Poisoning by other drugs, medicaments and biological substances, assault, subsequent encounter is a billable ICD-10-CM diagnosis code (T50.993D).

MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.

Associated Substances (64)

Official source data — entries quoted as published, in the Index’s own lookup phrasing

Substances from the official ICD-10-CM Table of Drugs and Chemicals that map to this code.

  • 5-Methoxypsoralen (5-MOP)
  • 8-Methoxypsoralen (8-MOP)
  • Acetohydroxamic acid
  • Acitretin
  • Arginine
  • Baking soda
  • Bergapten
  • BHA
  • Bromophenol blue reagent
  • Butylated hydroxy-anisole
  • Calcitonin
  • Calculus-dissolving drug
  • Canthaxanthin
  • Cetomacrogol
  • Chlorophyll
  • Cianidanol
  • Clodronic acid
  • Coenzyme A
  • Cogalactoiso-merase
  • Collagen
  • Colorant
  • Cyclamate
  • Deanol (aceglumate)
  • Diacetyl monoxime
  • Elcatonin
  • Epomediol
  • Etidronate
  • Etidronic acid (disodium salt)
  • Etretinate
  • Fat suspension, intravenous
  • Gallium citrate
  • Gelsemine
  • Gluconic acid
  • Glycerophosphate
  • Guaiac reagent
  • Inositol
  • Isotretinoin
  • Levocarnitine
  • Levoglutamide
  • Macrogol
  • Methionine
  • Methoxsalen
  • Methylethyl cellulose
  • Monooctanoin
  • Octanoin
  • Orazamide
  • Ornithine aspartate
  • Palm kernel oil
  • Parathormone
  • Parathyroid extract
  • Phenaphthazine reagent
  • Protein hydrolysate
  • Psoralens (medicinal)
  • Serotonin
  • Silibinin
  • Silymarin
  • Teriparatide (acetate)
  • Thioctamide
  • Thioctic acid
  • Tidiacic
  • Tiopronin
  • Tragacanth
  • Ursodeoxycholic acid
  • Ursodiol

Official Coding Guidelines

Official source data — quoted verbatim from the CMS/NCHS Official Guidelines

Official source data — quoted verbatim from the CMS/NCHS Official Guidelines

Verbatim excerpts from the ICD-10-CM Official Guidelines for Coding and Reporting (CMS/NCHS) that govern this code.

Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88)

5) The occurrence of drug toxicity is classified in ICD-10-CM as follows: (a) Adverse Effect When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug (T36-T50). The code for the drug should have a 5 th or 6th character “5” (for example T36.0X5-) Examples of the nature of an adverse effect are tachycardia, delirium, gastrointestinal hemorrhaging, vomiting, hypokalemia, hepatitis, renal failure, or respiratory failure.

Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88)

(b) Poisoning When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5 th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88)

(c) Underdosing Underdosing refers to taking less of a medication than is prescribed by a provider or a manufacturer’s instruction. Discontinuing the use of a prescribed medication on the patient's own initiative (not directed by the patient's provider) is also classified as an underdosing. For underdosing, assign the code from categories T36-T50 (fifth or sixth character “6”). Documentation of a change in the patient’s condition is not required in order to assign an underdosing code. Documentation that the patient is taking less of a medication than is prescribed or discontinued the prescribed medication is sufficient for code assignment.

Decision Points

The directives on this code's own record, as a pre-claim checklist.

  1. A 7th character applies in this family. Confirm the documented encounter matches the character assigned. See the official 7th-character definitions and this code’s variants
  2. Sequencing: 7 Code First instructions — the underlying condition is sequenced before this code when present. See the Code First notes
  3. 4 Use Additional Code instructions — report the named additional code(s) when the documentation supports them. See the Use Additional Code notes
  4. 1 Excludes1 entry — codes named there are generally not reported together with this code (Guidelines I.A.12.a). See the Excludes1 notes
  5. 5 Excludes2 entries — those conditions are not part of this code and may be reported additionally when documented. See the Excludes2 notes

Checklist rows are derived from this code's own official directives; the wording of each check is MedCoder editorial. The official notes themselves are in the sections each row links to.

Verify Before Coding

  • No Medicare Code Editor or MS-DRG Definitions Manual restrictions apply to this code.

From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.

Relationships & Classification

MedCoder structured relationships — computed from published CMS and AHRQ datasets

Other codes that name T50.993D or its code family, from the CMS ICD-10-CM tabular instructional notes. Tabular-note edges are stored at the code family level that carries each note.

Referenced by 1 Excludes1 note: T38 — Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (via T50.9.-).

These codes’ tabular lists mark this diagnosis as mutually exclusive — not reported together unless the conditions are documented as unrelated.

Referenced by 12 Excludes2 notes across 2 chapters: T46.5 — Poisoning by, adverse effect of and underdosing of other antihypertensive drugs (via T50.-), T80 — Complications following infusion, transfusion and therapeutic injection (via T50.-), T80-T88 — Complications of surgical and medical care, not elsewhere classified (T80-T88) (via T50.-), T81 — Complications of procedures, not elsewhere classified (via T50.-), T82 — Complications of cardiac and vascular prosthetic devices, implants and grafts (via T50.-), T83 — Complications of genitourinary prosthetic devices, implants and grafts (via T50.-), T84 — Complications of internal orthopedic prosthetic devices, implants and grafts (via T50.-), T85 — Complications of other internal prosthetic devices, implants and grafts (via T50.-), T86 — Complications of transplanted organs and tissue (via T50.-), T87 — Complications peculiar to reattachment and amputation (via T50.-), T88 — Other complications of surgical and medical care, not elsewhere classified (via T50.-), Y63 — Failure in dosage during surgical and medical care (via T50.-).

These codes’ tabular lists name this diagnosis as distinct — both may be reported when both are documented.

Referenced by 20 Code First instructions across 13 chapters: D64.2 — Secondary sideroblastic anemia due to drugs and toxins (via T50.-), E03.2 — Hypothyroidism due to medicaments and other exogenous substances (via T50.-), E09 — Drug or chemical induced diabetes mellitus (via T50.-), F02 — Dementia in other diseases classified elsewhere (via T50.-), G92.8 — Other toxic encephalopathy (via T50.-), G92.9 — Unspecified toxic encephalopathy (via T50.-), H35.38 — Toxic maculopathy (via T50.-), H91.0 — Ototoxic hearing loss (via T50.-), I42.7 — Cardiomyopathy due to drug and external agent (via T50.-), K22.1 — Ulcer of esophagus (via T50.-), K71 — Toxic liver disease (via T50.-), L53.0 — Toxic erythema (via T50.-), M34.2 — Systemic sclerosis induced by drug and chemical (via T50.-), N14 — Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions (via T50.-), P58.4 — Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn (via T50.-), Z91.12 — Patient's intentional underdosing of medication regimen (via T50.-), Z91.13 — Patient's unintentional underdosing of medication regimen (via T50.-), Z91.14 — Patient's other noncompliance with medication regimen (via T50.-), Z91.A2 — Caregiver's intentional underdosing of patient's medication regimen (via T50.-), Z91.A3 — Caregiver's unintentional underdosing of patient's medication regimen (via T50.-).

Each of these codes carries a Code First note naming this condition — when that code is reported, THIS code is sequenced first, ahead of it.

Referenced by 100 Use Additional Code instructions across 15 chapters: D46 — Myelodysplastic syndromes (via T50.-), D52.1 — Drug-induced folate deficiency anemia (via T50.-), D59.0 — Drug-induced autoimmune hemolytic anemia (via T50.-), D59.2 — Drug-induced nonautoimmune hemolytic anemia (via T50.-), D59.39 — Other hemolytic-uremic syndrome (via T50.-), D61.1 — Drug-induced aplastic anemia (via T50.-), D64.2 — Secondary sideroblastic anemia due to drugs and toxins (via T50.-), D70.2 — Other drug-induced agranulocytosis (via T50.-), D72.12 — Drug rash with eosinophilia and systemic symptoms syndrome (via T50.-), D84.821 — Immunodeficiency due to drugs (via T50.-), D89.3 — Immune reconstitution syndrome (via T50.-), E03.2 — Hypothyroidism due to medicaments and other exogenous substances (via T50.-), E06.4 — Drug-induced thyroiditis (via T50.-), E09 — Drug or chemical induced diabetes mellitus (via T50.-), E16.0 — Drug-induced hypoglycemia without coma (via T50.-), E22.1 — Hyperprolactinemia (via T50.-), E23.1 — Drug-induced hypopituitarism (via T50.-), E24.2 — Drug-induced Cushing's syndrome (via T50.-), E25.8 — Other adrenogenital disorders (via T50.-), E27.3 — Drug-induced adrenocortical insufficiency (via T50.-), +80 more.

These codes instruct coders to additionally report this code when it applies.

Referenced by 1 Code Also instruction: Z91.1 — Patient's noncompliance with medical treatment and regimen (via T50.-).

These codes suggest coding this condition alongside when both are present.

MS-DRG Grouper Relationships (FY2026)

Potential MS-DRG participation — not a DRG assignment.

Not on the CMS CC/MCC list — as a secondary diagnosis this code does not change MS-DRG severity.

Named in the grouper logic of 2 MS-DRGs: DRG 949 (MDC 23), DRG 950 (MDC 23).

From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.

Clinical classification (AHRQ CCSR):INJ059 — Poisoning by drugs, subsequent encounter (default).

Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.

Related Codes

Same injury, other encounter phase

Same injury, coded at a different phase of treatment via the 7th character.

T50.993A — Poisoning by other drugs, medicaments and biological substances, assault, initial encounterCompare T50.993D vs T50.993A →, T50.993S — Poisoning by other drugs, medicaments and biological substances, assault, sequela

Same clinical category (CCSR)

AHRQ's Clinical Classifications Software groups these diagnoses under the same clinical category (Poisoning by drugs, subsequent encounter).

+711 more

Contextual Map

Every relationship of T50.993D in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Run T50.993D with these 24 related codes in Claim Check

Hierarchy

Referenced by Excludes1 notes

Referenced by Excludes2 notes (12)

Referenced by Code First instructions (20)

Referenced by Use Additional Code instructions (100)

  • D46 — Myelodysplastic syndromes[Use Additional Code](via T50.-): “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • D52.1 — Drug-induced folate deficiency anemia[Use Additional Code](via T50.-): “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • D59.0 — Drug-induced autoimmune hemolytic anemia[Use Additional Code](via T50.-): “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • D59.2 — Drug-induced nonautoimmune hemolytic anemia[Use Additional Code](via T50.-): “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • D59.39 — Other hemolytic-uremic syndrome[Use Additional Code](via T50.-): “code, if applicable, for adverse effect to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • D61.1 — Drug-induced aplastic anemia[Use Additional Code](via T50.-): “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • D64.2 — Secondary sideroblastic anemia due to drugs and toxins[Use Additional Code](via T50.-): “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • D70.2 — Other drug-induced agranulocytosis[Use Additional Code](via T50.-): “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
  • and 92 more

Referenced by Code Also instructions

Clinical classification (CCSR)

MS-DRG Grouper

MDC crossing

  • MDC 23 — Factors Influencing Health Status and Other Contacts with Health Services[MDC crossing]: “Factors Influencing Health Status and Other Contacts with Health Services — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 1,235 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2026

Drugs & chemicals (64)

  • 5-Methoxypsoralen (5-MOP) — 5-Methoxypsoralen (5-MOP) — Poisoning, Assault [Drug table]: “5-Methoxypsoralen (5-MOP) (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • 8-Methoxypsoralen (8-MOP) — 8-Methoxypsoralen (8-MOP) — Poisoning, Assault [Drug table]: “8-Methoxypsoralen (8-MOP) (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • Acetohydroxamic acid — Acetohydroxamic acid — Poisoning, Assault [Drug table]: “Acetohydroxamic acid (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • Acitretin — Acitretin — Poisoning, Assault [Drug table]: “Acitretin (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • Arginine — Arginine — Poisoning, Assault [Drug table]: “Arginine (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • Baking soda — Baking soda — Poisoning, Assault [Drug table]: “Baking soda (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • Bergapten — Bergapten — Poisoning, Assault [Drug table]: “Bergapten (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • BHA — BHA — Poisoning, Assault [Drug table]: “BHA (Poisoning, Assault)”— CMS Table of Drugs and Chemicals · icd10cm-fy2026
  • and 56 more

Nearest codes (40)

Change history

  • FY2016 — In the code set at ICD-10-CM adoption [Change history]— CMS release files (code change ledger) · icd10cm-fy2016

Common coding questions

Does T50.993D require a 7th character?

Yes. The appropriate 7th character is to be added to each code from category T50.

Sources for this page

Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.

Code, title, tabular notes and index terms Official source data
CMS/CDC ICD-10-CM FY2026 tabular list, index and tables, effective October 1, 2025 Release, file and checksum · Publisher’s page
Coding guidelines Official source data
ICD-10-CM Official Guidelines for Coding and Reporting (FY2026), quoted by section Release, file and checksum · Publisher’s page
Claim edits Official source data
CMS Definitions of Medicare Code Edits — v43.1 (April 2026) Release, file and checksum · Publisher’s page
Inpatient payment groups Official source data
CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43 Release, file and checksum · Publisher’s page
Change history and date-of-service validity Official source data
CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
Comparisons, relationships and the contextual map MedCoder structured relationship
Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
Summary and FAQ answers MedCoder explanation
Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.

Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates

Change history

  • FY2016 — October 1, 2015
    In the code set at ICD-10-CM adoption
    Poisoning by other drugs, medicaments and biological substances, assault, subsequent encounter

No changes since FY2016 — additions, deletions, description changes and billable-status changes are tracked through FY2027 (effective October 1, 2026), and none are recorded for this code. Note changes are tracked from FY2027 only.

Nearest Codes in This Family

Official ICD-10-CM classifications closest to T50.993D in its code family, with their registry titles.

View all codes in the T50 family